These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 30715469

  • 1. Influenza Vaccines: Good, but We Can Do Better.
    Paules CI, Fauci AS.
    J Infect Dis; 2019 Apr 08; 219(Suppl_1):S1-S4. PubMed ID: 30715469
    [No Abstract] [Full Text] [Related]

  • 2. How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines.
    Rudraraju R, Mordant F, Subbarao K.
    J Infect Dis; 2019 Apr 08; 219(Suppl_1):S81-S87. PubMed ID: 30715386
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
    Crank MC, Mascola JR, Graham BS.
    J Infect Dis; 2019 Apr 08; 219(Suppl_1):S107-S109. PubMed ID: 30715413
    [No Abstract] [Full Text] [Related]

  • 5. Universal Influenza Vaccine Approaches Using Full-Length or Head-Only Hemagglutinin Proteins.
    Ross TM.
    J Infect Dis; 2019 Apr 08; 219(Suppl_1):S57-S61. PubMed ID: 30715379
    [Abstract] [Full Text] [Related]

  • 6. Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection.
    Eichelberger MC, Monto AS.
    J Infect Dis; 2019 Apr 08; 219(Suppl_1):S75-S80. PubMed ID: 30715357
    [Abstract] [Full Text] [Related]

  • 7. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2012 Mar 16; 87(11):97-108. PubMed ID: 22462204
    [No Abstract] [Full Text] [Related]

  • 8. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM, Janjua NZ, Sabaiduc S, De Serres G, Winter AL, Gubbay JB, Dickinson JA, Fonseca K, Charest H, Bastien N, Li Y, Kwindt TL, Mahmud SM, Van Caeseele P, Krajden M, Petric M.
    J Infect Dis; 2014 Jul 01; 210(1):126-37. PubMed ID: 24446529
    [Abstract] [Full Text] [Related]

  • 9. Dynamic Perspectives on the Search for a Universal Influenza Vaccine.
    Saad-Roy CM, McDermott AB, Grenfell BT.
    J Infect Dis; 2019 Apr 08; 219(Suppl_1):S46-S56. PubMed ID: 30715467
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2014 Mar 14; 89(11):105-15. PubMed ID: 24707515
    [No Abstract] [Full Text] [Related]

  • 13. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2013 Oct 18; 88(42):449-63. PubMed ID: 24159668
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2014 Mar 07; 89(10):93-104. PubMed ID: 24707514
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Influenza. Synthetic vaccine strain may speed up pandemic response.
    Kupferschmidt K.
    Science; 2013 May 17; 340(6134):797. PubMed ID: 23687018
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.